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Abstract
In Australia, compared with other developed countries the many and varied programs which
comprise public health have continued to be funded poorly and unsystematically, particularly given
the amount of publicly voiced political support.
In 2003, the major public health policy developments in communicable disease control were in the
fields of SARS, and vaccine funding, whilst the TGA was focused on the Pan Pharmaceutical crisis.
Programs directed to health maintenance and healthy ageing were approved. The tertiary
education sector was involved in the development of programs for training the public health
workforce and new professional qualifications and competencies. The Abelson Report received
support from overseas experts, providing a potential platform for calls to improve national funding
for future Australian preventive programs; however, inconsistencies continued across all
jurisdictions in their approaches to tackling national health priorities. Despite 2004 being an
election year, public health policy was not visible, with the bulk of the public health funding available
in the 2004/05 federal budget allocated to managing such emerging risks as avian flu. We conclude
by suggesting several implications for the future.
Introduction
Public health is a small component of the health system,
both in terms of budgetary allocation at either state or
national level and in terms of the number of practitioners.
It incorporates a myriad of activities; legislation and regu-
lation for health protection, preventive services directed at
specific diseases and populations, and health promotion
programs geared towards particular risk factors and vul-
nerable groups in the community. As such, it looks like a
disparate collection of programs and investments.
In Australia, there is also confusion about the very termi-
nology of 'public health'. Despite its extensive history and
global understanding, in Australia the term is used vari-
ously; to refer to publicly funded health services, and
interventions (regardless of the funding source) which are
aimed at primary prevention and the promotion and pro-
tection of the public health ('rats and drains'). This has led
to an increasing number of jurisdictions adopting the
label 'population health'.
Renovation of the public health system has been on the
international agenda for some years. In the US, the Insti-
tute of Medicine released reports during 2003 about the
public health workforce required for 21st century chal-
lenges [1], as well as re-visited and updated its landmark
report, The Future of Public Health in the 21st Century[2].
In the UK, following the path-breaking review of the NHS
by Derek Wanless[3] the Treasury commissioned him, in
2003, to undertake a review of whole-of-government
effort in public health. Arising in part from the challenges
that confronted Canada during the outbreak of sudden
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acute respiratory syndrome (SARS) in 2003, a new public
health agency, at arms length from government, is being
created.
Public health in Australia, meanwhile, remained frag-
mented – by programs, across jurisdictions (particularly
the states and territories) – and without a systematic
approach to funding, organisation, or conceptualisation.
In 2003/04, the gap between rhetoric and funding contin-
ued to be noticeable, along with the tension between
framing priorities for popular appeal versus the technical
language of the evidence base.
This article will examine some of the indicative develop-
ments of public health in Australia in 2003/04. The key
developments are identified, and a number of them are
selected for in-depth analysis. In this article, we use the
traditional meaning of the term 'public health' and focus
on activities which are usually designed to promote and
protect the health of the population. The drivers for these
developments, their short term implications and some
signposts for the future are suggested.
2003/04 in Retrospect: A brief chronicle
While early global anxiety over SARS occupied headlines
between February and May, the more persistent popular
headline in 2003 focused on obesity. Summits were held
in NSW and Victoria, while the National Obesity Task-
force was convened under the auspice of the Australian
Health Ministers Council (AHMC).
When Kay Patterson was the Federal Health Minister, she
declared that prevention was the fourth pillar of Medicare
and she wanted to be 'Minister for Prevention'. Indeed,
the 2003/04 federal budget, although limited, contained
a bundle of initiatives entitled "Prevention on the Health
Agenda". In particular, a number of immunisation and
health promotion programs were included.
Significant amongst the funding initiatives for public
health announced in 2003/04 was government support
for the meningococcal vaccine. Although this was the cul-
mination of many months of careful planning, a percep-
tion existed that this only occurred after considerable
public interest in and anxiety about deaths from out-
breaks of this disease.
Further changes to the recommended schedule in 2003
were made by the Australian Technical Advisory Group on
Immunisation (ATAGI), in particular the inclusion of
pneumococcal and varicella vaccines; however, these did
not result in similar prescribed vaccine programs or in
similar funding. These three developments are reviewed
in greater detail in the next section.
The National Public Health Partnership (NPHP) and the
AHMC adopted the influenza pandemic plan in October
2003, and with the advent of the newly-identified disease
SARS, as well as outbreaks of meningococcal disease,
management and prevention of communicable diseases
was prominent. Following on from the significant fund-
ing boost for bioterrorism preparedness in 2002/03, pub-
lic health preparedness became a more generic theme.
The arrival of SARS occupied the national popular and
political imagination as well as tested the infrastructure
capacity of public health. Australia fared well during the
outbreak. Apart from escaping with only six Australian
cases, it provided an opportunity to establish a coordi-
nated approach between the Commonwealth and the
states/territories and also contributed to the global epide-
miological investigation and prevention effort. SARS also
prompted amendments to the Quarantine Act [4].
While the recall following the Pan Pharmaceutical crisis
put the Therapeutic Goods Administration (TGA) under
the spotlight, it also managed to conclude negotiations
that had been in train for several years on a Trans-Tasman
regulatory regime and authority. Also on the regulatory
front, the Australian New Zealand Food Regulation Min-
isterial Council endorsed a nutrition, health and related
claims policy guidelines and established a review of genet-
ically modified (GM) labeling of foods [5]. All these
developments pointed to the global nature of public
health, and the intersection between public health activi-
ties and the economy.
Policy development in public health has never been con-
fined to a set of health programs, and in 2003/04, the lead
was often taken from outside the health sector. Most sig-
nificant was the adoption of the National Agenda for Early
Childhood [6], pushed by public health advocates for
child health since the mid 1990s. The National Public
Health Partnership responded by coordinating a scoping
of child health strategies across Australia. Elsewhere in
Government, "Promoting and Maintaining Good Health"
was adopted as one of the National Research Priorities [7].
Healthy ageing also emerged as a policy theme in Ageing
Research.
Public health workforce development was pursued out-
side the mainstream education and training arrangements
for public health in universities. The Community Services
and Health Training Board commissioned a consultative
process to develop population health competencies for
the Vocational Education and Training (VET) sector [8].
New population health qualifications and competencies
were proposed for incorporation into the Health Training
Package – including certificates in population health andAustralia and New Zealand Health Policy 2005, 2:7 http://www.anzhealthpolicy.com/content/2/1/7
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in environmental health, and diplomas in population
health and in indigenous environmental health.
The release in 2003 of the report "Returns on Investments
in Public Health: an epidemiological and economic anal-
ysis" [9] (often referred to as the Abelson report), may
have a significant impact in subsequent years. Commis-
sioned several years earlier by the Population Health Divi-
sion of the Department of Health and Ageing (DoHA), the
report experienced a relatively low profile until Derek
Wanless visited from the UK. Having chaired a review that
contributed to a significant budgetary increase for the
NHS, Wanless had been commissioned by the British
Treasury to examine prevention across government. In
September 2003, at a meeting in Canberra with senior
officials across key agencies, Wanless marveled at the
value of the Abelson report, described in more detail
below.
Although 2004 was an election year, public health policy
was neither visible during the campaign or in policy devel-
opment more generally. The Federal Government's initia-
tive to wind up the National Occupational Health and
Safety Commission received little publicity and comment,
even though it indicated the Commonwealth's increasing
tendency to pursue its own pathway, separate from states
and territories, and to bring the functions of statutory
bodies into departments.
Jurisdictional and annual reports show that across the
states and territories, there were multiple plans, draft
guidelines, meetings, episodic training and programs
across a broad range of areas. Some health issues are being
taken up across jurisdictions – particularly tobacco con-
trol, sexually transmitted infections, Aboriginal health,
and vaccination. Innovative activities were reported in
some jurisdictions, such as a new Health Impact Assess-
ment Branch and a new public health training program in
Western Australia. There was, however, no apparent con-
sistency in health priorities across the nation, and an
apparent divergence in the interests of the states/territo-
ries and the federal government.
Obesity: Old or new frontier for health promotion?
While the "prevention and management of overweight
and obesity" agenda may have appeared to many observ-
ers as a new issue in 2003, its arrival was preceded by sev-
eral years of intensive work. The NHMRC had released
Acting on Australia's Weight: Strategic plan for the preven-
tion of overweight and obesity in 1997 [10], the same year
the ABS published the findings from the 1995 National
Nutrition Survey, revealing that 45% of men and 29% of
women in Australia were overweight, with an additional
18% of men and women classified as obese [11]. Further-
more, overweight and obesity were more common in
lower socio-economic groups, in rural populations, in
some immigrant groups, and in Aboriginal and Torres
Strait Islander (ATSI) peoples.
Despite longstanding national cooperation on nutrition
(since the days of the National Better Health Program in
the late 1980s), and even more recent national coopera-
tion on physical activity, public and political imagination
was not captured until the same issues were recast as
'obesity', with a focus in particular on childhood obesity.
Following from the NSW Childhood Obesity Summit in
late 2002, the Australian Health Ministers agreed that a
national approach was required and established a
National Obesity Taskforce [12].
In 2003, NSW Health released it's response to the Summit
recommendations and supported the vast majority of the
145 resolutions [13]. The Victorian Department of
Human Services also held a summit [14], while Healthy
Weight 2008 – Australia's Future was released by the
Commonwealth [15]. The NHMRC joined in with release
in late 2003 of clinical practice guidelines for general prac-
titioners and other health professionals [16].
While the specifics vary, the major themes and strategies
are captured in Healthy Weight 2008. These are summa-
rised in the Table 1.
The Commonwealth strategy is, however, relatively weak
on intersectoral policy and regulatory measures. As an
illustrative example of the contrast at the state level,
implementation in NSW now ranges from school physical
activity and nutrition survey, to a school canteen strategy,
to negotiating with Commercial Television Australia
about their code of practice on advertising in peak chil-
dren's viewing hours. The Commonwealth apparently
chose not to consider how it might exercise its relevant
taxation or legislative powers, despite the history of health
promotion pointing to the importance of public policy
measures beyond the health system.
An examination of the manner in which the obesity issue
was framed, and the details contained in the national
strategy, raises a number of issues and questions:
- Why was framing the issues as 'obesity' more successful
than the focus on 'nutrition' and 'physical activity'? Why
did 'obesity' gain traction while the other terms did not?
- Why did the Commonwealth opt for the softer program-
matic approach, rather than tackle obesity with stronger
public policy measures (such as taxation and regulation),
and demonstrate its national leadership capacity?Australia and New Zealand Health Policy 2005, 2:7 http://www.anzhealthpolicy.com/content/2/1/7
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- Was the absence of stronger public policy measures
because 'obesity' is regarded as largely a health issue,
rather than a whole-of-government issue? Or was the Gov-
ernment waiting to see if the US opposed the WHO Glo-
bal Strategy on account of the strength of the industry
lobby?
- After a number of years of public concern about eating
disorders and whether they arise in part because of pro-
motion of certain types of body image, was the 'obesity'
label a backward step for mental health and a return to
traditional images of beauty?
- Is there a risk that people, including children, who are
labeled as 'overweight and obese' will be stigmatised? To
what extent have the voices of affected communities been
incorporated into the development of national strategies,
if at all?
- Given the correlation between obesity and socioeco-
nomic disadvantage, how would the proposed strategy
not exacerbate those inequalities?
- Were children targeted because they are a "captive audi-
ence" and therefore easy targets or did the evidence sug-
gest the best return on investment (in terms of health gain
and managing demand on the health care system) would
come from a focus on children?
- Was the move to appeal to a populist agenda, while
simultaneously progressing the longer-term agenda of
tackling health inequalities through multi-sectoral part-
nerships, a triumph for public health advocates?
These complex threads are interwoven. For the moment,
the publicly enunciated agenda represents a confluence of
a number of rationales.
Vaccines: From evidence base to funding
During 2003–4 three new vaccines were added to the
schedule of recommended vaccines for Australians (an
additional change to the schedule, recommending that
polio immunisation be changed from oral to injected
(IPD) vaccine, will not be discussed here). These vaccines
protect against serogroup C meningococcal disease, some
strains of Pneumococcal disease, and chicken pox
Table 1: Major themes and strategies in public health weight programs
A. SETTINGS KEY STRATEGIES
Child care Good practice standards that incorporate physical activity guidelines and dietary guidelines 
for children
Schools As above plus active transport to school and programs to reduce excessive TV watching 
and computer games
Primary care services Support GPs to screen body mass index and implement lifestyle scripts
Community-based support programs for management of overweight
Family and community care services As per childcare settings
Maternal and infant health Extend healthy eating and active living programs; breastfeeding support programs; 
disseminate information resources for parents; 'baby friendly' accreditation for hospitals 
and health services;
Neighborhoods and community organisations Healthy eating and active living initiatives within existing programs; support improved 
physical and infrastructure planning; develop good practice 'tools'
Workplaces Support active transport programs; healthy eating and active living support for parents 
with young children
Food supply Accreditation for food service outlets; cold chain management initiatives; encourage 
reduction of energy content and size of servings in food industry
Media and marketing Monitor effectiveness of Children's Television Standards
B. NATIONAL ACTION KEY STRATEGIES
Support for families and community-wide education Social marketing; promotion of fruits and vegetables; national awards for settings-based 
programs
'Whole of Community' demonstration areas Demonstration projects, with professional support unit and clearinghouse; dissemination 
and professional development strategy
Evidence and performance monitoring Surveillance system and tracking indicators; policy research
Coordination and capacity-building Leadership program for obesity prevention; support professional networks for 
dissemination of good practiceAustralia and New Zealand Health Policy 2005, 2:7 http://www.anzhealthpolicy.com/content/2/1/7
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(varicella) [17]. For the first time, not all of these recom-
mended vaccines will be funded by Government.
Prior to the introduction of these vaccines, the quality of
information about the epidemiology and burden of dis-
ease caused by these three infections was extremely varia-
ble. Meningococcal disease has been notifiable for many
years, and in Australia almost all is caused by serogroups
B and C. Whilst serogroup B predominantly occurs in
young children, a new strain of serogroup C [18] was caus-
ing increasing anxiety amongst public health profession-
als, microbiologists, staff of accident and emergency
departments, intensive care units and of course the public
and media.
The cause of anxiety amongst health professionals was
based on the fact that this new strain carried a high fatality
rate with severe after-effects in a high proportion of survi-
vors. The attack rate, although still small, was increasing
exponentially each year and reaching an important trigger
point, and the majority of cases were now healthy teenag-
ers and young adults. Although an initial accelerated
catch-up programme was introduced for teenagers (the
major risk group), the new conjugated vaccine was also
introduced to the childhood schedule at age one, as from
that age, only one dose (at a cost of $30–$60) was consid-
ered necessary for full protection from serogroup C
disease.
Pneumococcal disease became notifiable in 2001, how-
ever, with such a short surveillance history, not much is
certain locally, epidemiologically speaking, about risk
groups and effects (although there is no reason to suppose
that it has a different epidemiological pattern from other
developed countries). Pneumococcal disease is thought to
occur at least four times as often as meningococcal dis-
ease, is known to carry major sequelae and has a high case
fatality rate. For some time it has been known to be even
more common amongst the indigenous Australian popu-
lation with attack rates of up to 1 in 500 each year, knowl-
edge which underpinned the 1999 decision to target
Aboriginal people for free vaccination as soon as the new
vaccines became available. Unfortunately at about $120
per dose, conjugate pneumococcal vaccine is very expen-
sive and, for the protection of the very young children
who bear the brunt of this disease, it is licensed only to be
given as a three dose course, making provision of this vac-
cine to all Australian children prohibitively expensive.
Varicella, predominantly a childhood disease, is caused by
a Herpes virus known as herpes virus 3 or varicella-zoster
virus or VZV. It is not notifiable in Australia; therefore no
epidemiological population data are available. A reliable
varicella vaccine has been available since the mid 1990s in
the USA and is part of American routine immunisation
schedule. This vaccine became available in Australia in
2000, at a cost of about $75–$90 per dose, with two doses
being required for full protection.
In 2003 the Commonwealth provided its periodic update
on the Australian Standard Vaccination Schedule, the list
of vaccines it provides as appropriate at no cost to all Aus-
tralians [19]. For the first time it differed from the
National Immunisation Program recommendations in
that besides meningococcal serogroup C conjugate vac-
cines, pneumococcal vaccine, varicella vaccine and also
inactivated polio (injected) vaccine were also recom-
mended: however, funding was only secured for menin-
gococcal conjugate vaccines, with a continuation of the
provision of pneumococcal vaccines for indigenous chil-
dren. As a result, although recommended, pneumococcal
and varicella vaccines were not funded and parents would
have to decide whether or not to pay for them.
These funding decisions had important implications. Vac-
cines protect most of their recipients from unpleasant and
sometimes life-threatening disease. One view, subscribed
to in the UK, is that ethically, children should not be
denied access because of their parents' inability to pay.
These vaccines have been the subject of several cost-bene-
fit studies, with generally favourable to extremely favour-
able pro-vaccination results. Table 2 summarises the
various models for framing policy.
The policy of funding meningococcal serogroup C vaccine
was built on a sustained program of epidemiological evi-
dence, ethical decision-making and public support (and
was arguably honed by public pressure). Pneumococcal
disease and varicella vaccination programs however, were
neither supported by good local epidemiological evidence
nor respectable levels of public awareness about these dis-
eases. There had not been a similar program of sustained
policy building to support or drive a decision to fund
these vaccines. As a funding policy, this was noteworthy in
that it marked a departure from previous policies where
all recommended vaccines were fully funded by govern-
ments. National vaccination policy is designed to advise
vaccination policy makers and practitioners of the most
up-to-date thinking about optimal vaccination schedules
for Australian children, and is not therefore proscriptive,
unlike the United Kingdom (UK). Changing or adding
vaccines to the recommended schedule is therefore an
advisory matter, and the question of funding the vaccina-
tion program is decided separately.
Cost benefit studies indicate pneumococcal polysaccha-
ride and conjugate vaccines can be cost-effective although
vaccine costs clearly affect ratios of cost to benefit greatly
[20,21]. Varicella vaccine is more contentious, because
this disease is more severe in older cases, and it is possibleAustralia and New Zealand Health Policy 2005, 2:7 http://www.anzhealthpolicy.com/content/2/1/7
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that one result of a vaccination program could be an
increase in older cases (and therefore severe disease).
Whilst the vaccine undoubtedly works, there is no consen-
sus about precisely who should be vaccinated for maxi-
mum population health as well as cost benefit, and again
potential financial savings are highly dependant upon
vaccine costs [22,23].
The costs of preventive vaccine programs and curative
medicine are funded from different sources. Vaccines are
currently funded by the Commonwealth and subsidised
through the states according to local vaccination policies,
whilst the costs of curing cases of these diseases is broadly
funded through the Medicare and private health insur-
ance systems. Savings to Medicare and health insurance
funds, as a result of successful vaccination programs, are
not automatically transferred to the Commonwealth to
fund the vaccine programs. Savings – or costs – in one area
are of little interest or importance to other program areas.
In 2004 the Government revised this funding policy, pro-
viding funding for conjugate pneumococcal vaccines pop-
ulation immunisation program for all children under
seven years of age (as well as specific people in other risk
groups) to commence in January 2005. The Australian
Technical Advisory Group on Immunisation (ATAGI)
completed Ministerial reports on both varicella and polio
(injected as well as oral) vaccination late in 2004, and it is
possible that programs for these vaccines will also be
funded in the future.
Federal budget: Prevention on the Health Agenda?
The 2002/2003 Federal Budget papers stated that "the
Government is committed to making disease prevention
and health promotion a fundamental pillar of the health
system": however, this was not evident in the subsequent
2003/2004 budget. The Government's Focus on Preven-
tion Package in 2002/03 aimed to incorporate disease pre-
vention into the core business of the primary health care
system and was reflective of how the public health agenda
was evolving at the national level [24]. The package was
comprised largely of a range of measures directed at spe-
cific diseases, plus a bundle of initiatives for general prac-
titioners, also referred to as the "primary health care
system".
Amongst health conditions affecting Australians, breast
cancer received the most attention, with the National
Breast Cancer Centre being funded to develop a partner-
ship approach to the review and dissemination of new
information, along with information, support and man-
agement initiatives for rural women diagnosed with
breast cancer. Hepatitis C also received some attention,
with funding for national education and prevention
Table 2: New VPD awareness matrix
Argument – do we 
have good 
epidemiological 
evidence
What are the 
political risks in not 
funding this 
vaccine?
What are the risks 
perceived by health 
professionals
What are the 
perceived risks and 
outrage by general 
public
Ethics – what is in it 
for the 
stakeholders?
Meningococcal sg C 
disease
Yes: notifiable disease 
for many years – good 
detailed and 
longitudinal evidence
High political risk; Low Public frightened- 
recent high level of 
awareness amongst 
public, news coverage 
biased ++ to worst 
cases [26]
Much public support 
for gvt Vaccine 
provider contracts
Pneumococcal disease Some: notifiable since 
2000 so some local 
evidence, more from 
published materials 
from overseas
Med-low: public not 
highly aware of 
significance in children
High Public not anxious; 
news highlights 
occasionally but less 
general awareness 
(See * below)
Some public support 
for gvt Vaccine 
provider contracts
Varicella Little – not notifiable Low – viewed by 
many people as an 
insignificant and mild 
disease of childhood
Med Very little; whilst 
parents know this to 
be an unpleasant 
disease there is a 
general lack of 
awareness of 
complications, and 
vaccine not 
considered a high 
priority [27]
Vaccine provider 
contracts
(*Whilst there are several papers about the reasons older people, their families and health care providers use pneumococcal vaccines, there do not 
seem to be any published peer-reviewed studies of parental understanding of pneumococcal disease). Source [26] [27].Australia and New Zealand Health Policy 2005, 2:7 http://www.anzhealthpolicy.com/content/2/1/7
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projects. Financial support was offered for the SARS efforts
that had been undertaken by states and territories, in par-
ticular for providing medical personnel at international
airports. A clear process for assessing priorities under the
broad banded National Public Health Program was also
flagged.
For purposes of the budget, primary health care was
defined as general practitioners, and the measures funded
included:
• "Lifestyle prescriptions" to help GPs "raise community
awareness and understanding of benefits of preventive
health";
• Collaborative approach to learning, training education
and support systems;
• Coordinated care plans for people with chronic or termi-
nal conditions; and
• Involvement in multidisciplinary case conferencing.
The budget did not adopt a comprehensive approach to
the primary health care system, perhaps because many
community health services, which represent the other
important arm for delivery of public health services, are
the responsibility of states. The timetable for renewing
Public Health Outcome Funding Agreements (PHOFAs)
between the Commonwealth and states and territories in
2004 raised in the minds of some stakeholders, the possi-
bility that the Commonwealth might adopt a more com-
prehensive and strategic approach, linking public health
and primary health care funding streams.
Judging by the actual quantum of funds made available in
the 2003/2004 budget, it would seem that most elements
from the package did not actually receive additional fund-
ing, as shown in Table 3. Indeed, many of the GP initia-
tives, previously cast as improving primary health care,
were subsequently packaged as 'prevention'.
The combination of these measures reflected a tight fiscal
climate, with little growth in the overall health budget, as
well as that of other portfolios. It was also a package that
demonstrated relatively limited imagination, with sup-
port for established issues (such as breast cancer) and re-
packaging general practice measures that were already in
train. With Medicare spending "uncapped" (and targeted
public health programs "capped"), attaining more pre-
vention dollars through the GP sector may appear to be
one of the few ways to 'grow' dollars for prevention.
Although this could be considered to be consistent with
the Ottawa Charter of "reorienting health services", many
GPs are not trained in a population-based approach to
practice, and simply providing new for payments to all
represents an undifferentiated, uncoordinated and untar-
geted approach to prevention. If there is limited support
to GPs, and little monitoring, then these measures are
unlikely to translate into improved health outcomes.
Meanwhile, the strategic framework for chronic disease
prevention, adopted by the National Public Health Part-
nership in 2001, still lacked a policy and budgetary
response in 2003/04 and in 2004/05, while states/territo-
ries adopting varying measures singly.
Funding for the Tough on Drugs strategy was announced
outside the Focus on Prevention package; perhaps due to
Table 3: Additional federal funds (in millions) for new public health activities between 2003–2007
INITIATIVES 2003/04 2004/05 2005/06 2006/07
Community awareness 2.1 1.5 0.7 -
Primary care providers working together 2.7 4.6 4.6 4.5
Priority setting - - - -
S A R S 1 . 7 ---
National Breast Cancer Centre - - - -
Support for women with breast Cancer - - - -
Hep C prevention and education - - - -
Sharing healthcare - - - -
Annual health assessment for older Australians - - - -
Meningococcal C campaign 1.3 0.4 0.4 0.4
Preventing falls in older people - - - -
Coordinated care planning - - - -
Multidisciplinary case conferencing - - - -
Enhanced divisional quality use of medicines 10.9 17.0 19.2 21.6
GP education, support and community linkages - 1.4 - 1.7 - 1.8 - 1.8
Source: [28]Australia and New Zealand Health Policy 2005, 2:7 http://www.anzhealthpolicy.com/content/2/1/7
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the fact that the Tough on Drugs was the responsibility of
the Parliamentary Secretary therefore requiring a separate
communications strategy, or because the Prime Minister
has a strong personal interest in the illicit drug strategy.
The range of measures funded (which included introduc-
tion of retractable needle and syringe technology, address-
ing problems related to increased availability and use of
psycho stimulants, establishing a research fund, support-
ing alcohol and drug workforce development needs, pro-
moting access to drug treatment in rural areas, and
tackling problems faced by drug users with concurrent
mental health problems) certainly suggested more serious
government interest and commitment to illicit drugs.
The 2004/05 Budget indicated the Federal Government's
agenda in public health had narrowed considerably. $33
million new funding was announced for measures to
address emerging risks (such as emergency medicines
stockpile, disease surveillance and public health laborato-
ries, health security legislation and incidence response),
but only $5.2 million new funding was made available for
promotion of healthy lifestyles related to national health
priorities (for addressing such as tobacco, alcohol, drugs,
injury, and cancer). [25]
Drivers for Policy and Implications for Public Health
During the course of the Howard Government, there has
been a gradual process of re-casting the "landscape" of
interest groups and policy constituencies. Strong support
for breast cancer and zero-tolerance on illicit drugs con-
trasts sharply with the delays experienced in renewal of
the National HIV/Hepatitis C Strategy. The new promi-
nence given to meningococcal vaccine, child health and
obesity creates space for other interest groups: even if the
re-framing was shaped by nutrition and physical activity
lobbies, other clinical interests have been brought into the
picture. These developments illustrate how 'political' con-
siderations are important in determining 'public health
policy'.
It was interesting however, to observe the interest in pre-
vention from outside the health portfolio, particularly
from Treasury. This was motivated in part by the Intergen-
erational Report and concerns about both the sustainabil-
ity of Medicare as well as the social and economic cost
burden arising from an ageing society. This helped to
ensure interest in the Abelson Report[9].
Few countries have conducted research on return of
investment from prevention efforts. Australia was praised
by Derek Wanless at a high-level consultation for com-
pleting such an analysis, during his visit to Canberra while
conducting a review for the UK Treasury, "Securing Good
Health for the Whole Population"[26]. His final report
pointed to Australia and Netherlands as two countries
that were increasingly using economic evaluation in pub-
lic health programs. It will be interesting to see if public
health policy analysts and Treasury officials draw on this
report in future years. In the future it will be interesting to
see if the focus on high-visibility programs can demon-
strate short-term economic returns.
Given 2004 was an election year, the "political economy"
of prevention programs could arguably have become a
focus of future public health policy, with the 2003/4
agenda providing the Government with the opportunity
to gauge public reaction to this new positioning and
design their election campaign appropriately. This was,
however, not the case. The American emphasis on 'prepar-
edness' appears not to resonate with the Australian public
in the same way.
From the perspective of public health policy advocates,
some lessons that can be drawn from 2003/04 are:
• Government's response to public health proposals are
shaped by its understanding of the popular interest and
desire to communicate directly with the general public;
• Longer term public health issues which have struggled to
gain support can be progressed if they are cleverly shaped
to fit the Government's "formula";
• Develop and nurture new advocates, particularly in
seeking to engage with the broader health system; and
• Work with the media as partners rather than adversaries
These lessons need to be learned well and quickly, to assist
with moving the forum for public health policy debate
more into the public domain; beyond an essentially "in
house" discourse between politicians, researchers and
public health advocates. If a more engaged and informed
community takes up a public health issue, government
will be more likely to respond.
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